Profile of Fraunhofer ITEM

Institute director

© Photo Fraunhofer ITEM

Norbert Krug is professor of Immunology, Allergology and Clinical Airway Research and has been Medical Director of the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM since 2008. In 2014, he became coordinator of the Clinical Research Center Hannover (CRC Hannover) in addition. At the Hannover Medical School, he trained in internal medicine and also in respiratory medicine, allergology and intensive-care medicine. From 1991 to 1993, he was a research fellow at the University of Bochum, Germany, and the University of Southampton, UK. In 2000, he was awarded a full academic professorship in immunology, allergology and clinical airway research at the Hannover Medical School and became Division Director of Immunology, Allergology and Airway Research at Fraunhofer ITEM, where he played a leading role in setting up the clinical airway research department in the following years.

Professor Krug is a member of several international professional societies such as the German Respiratory Society, the European Respiratory Society, and the American Thoracic Society. His major research interests include translational medicine and clinical trials in allergy, asthma, and COPD, pathogenesis of allergic airway diseases (asthma, rhinitis and COPD), and air pollution and airway diseases. Professor Krug is a reviewer for numerous international journals in respiratory medicine and allergology and for a variety of research organizations. He is a member of the scientific advisory board of the German Society for Allergy and Clinical Immunology, a member of the German Center for Lung Research, and Deputy Spokesman of the Fraunhofer Group for Life Sciences. Prof. Krug took over the job of the institute’s executive director on January 1, 2017.

Organizational structure

Headed by the Institute Directors and the Executive Committee, Fraunhofer ITEM is organized in eight divisions. The institute‘s headquarters with most of its divisions are in Hannover (Germany), except for the Divisions of Pharmaceutical Biotechnology, which has its facilities in Braunschweig on the campus of the Helmholtz Center for Infection Research.

The Fraunhofer ITEM Division of Personalized Tumor Therapy is based in Regensburg‘s BioPark and was set up as a joint initiative of Fraunhofer ITEM, the Fraunhofer-Gesellschaft, and the University of Regensburg.

Facts and figures

At tht end of 2016, 303 people were employed at Fraunhofer ITEM. The institute's sponsors include industry and commercial associations, the public sector, and the EU. In 2016, external income amounted to 19 million euros. The institute's budget in 2016 reached a level of 27.7 million euros. For more details, please click on the below figures.

Development of Budget

Development of the Employees

Development of sponsors and external income

Would you like to learn more about Fraunhofer ITEM?

Annual report

The latest Fraunhofer ITEM Annual Report provides comprehensive information about the institute and recent research projects.

Institute chronicles

Please click below to learn more about the history of Fraunhofer ITEM since 1981.